For example, gene‐based restoration of AIM2 in colon cancer may be a novel approach to cure AIM2‐deficient cancers by restraining DNA‐PK and PI3K,13 whereas downregulation of AIM2 leads to inhibition of AIM2‐activated tumors. This evidence concerns the gene PRKDC and malignant colon neoplasm.